# Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)

> **NCT03849950** · NA · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 62 (actual)

## Conditions studied

- Lymphoma
- Lung Cancer
- Colo-rectal Cancer

## Interventions

- **OTHER:** SMARTCare
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT03849950
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-11
- **Primary completion:** 2020-09-28
- **Final completion:** 2020-09-28
- **Target enrollment:** 62 (ACTUAL)
- **Why stopped:** Recruitment was halted prematurely due to the COVID-19 pandemic.
- **Last updated:** 2021-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03849950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03849950, "Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03849950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*